Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
South Korea-based SK bioscience will advance a novel respiratory syncytial virus (RSV) monoclonal antibody (mAb) for glo...
Australia-based startup AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha the...
Researchers have opened a ‘window to the brain’ with a new diagnostic device that can tell how deadly brain ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (I...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
What was the scientific moment or data point that convinced you NK cell–derived extracellular vesicles could becom...
Singapore has one of the most advanced biotechnology industries. Singapore began building its biomedical sciences ecosys...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Duke-NUS Medical School in Singapore has noted the announcement by Boehringer Ingelheim of a Phase IIa clinica...
US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...
Dr. Peiqing Zhang, Scientific Director, Cytiva (Left) Dr. Timothy Tan, Associate Professor and Leading Investigator, NT...
To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors...
AusBiotech welcomes the Australian Government's announcement, made by the Minister for Trade and Tourism, Senator the Do...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undis...
Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...
